Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03635125 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine
A Phase 4 study of JNC 7 Stage 1 or 2 Hypertension, sponsored by Trinity Hypertension & Metabolic Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03635125: Completed Phase 4 study of JNC 7 Stage 1 or 2 Hypertension, sponsored by Trinity Hypertension & Metabolic Research Institute.
NCT03635125 is a Phase 4 study of JNC 7 Stage 1 or 2 Hypertension that has completed, run by Trinity Hypertension & Metabolic Research Institute. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03635125, a Phase 4 study of JNC 7 Stage 1 or 2 Hypertension, has completed, sponsored by Trinity Hypertension & Metabolic Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Study is to evaluate the effect of Nebivolol to treat high blood pressure compared to an already approved drug, Metoprolol ER with background treatment of Amlodipine.
Primary Outcome
Mean change by millimeters of mercury from baseline in trough Diastolic Blood Pressure
Conditions Studied
Interventions
- DRUG Nebivolol I
- DRUG Nebivolol II
- OTHER Baseline Washout Phase
Study Locations (1)
Texas
- Punzi Medical Center - Carrollton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-08-30 |
| Est. Completion | 2011-07-18 |
| Phase | Phase 4 |
What the finished NCT03635125 record still lists
NCT03635125 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 1 condition, with JNC 7 Stage 1 or 2 Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Nebivolol I is the first listed.
NCT03635125 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03635125 about?
NCT03635125 is a clinical study titled "Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine". Study is to evaluate the effect of Nebivolol to treat high blood pressure compared to an already approved drug, Metoprolol ER with background treatment of Amlodipine.
What is the current status of trial NCT03635125?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2010-08-30. Estimated completion is 2011-07-18.
What conditions does trial NCT03635125 study?
This clinical trial studies the following conditions: JNC 7 Stage 1 or 2 Hypertension.
What interventions are being tested in trial NCT03635125?
The interventions under investigation include: Nebivolol I (DRUG), Nebivolol II (DRUG), Baseline Washout Phase (OTHER).
Who is sponsoring clinical trial NCT03635125?
This trial is sponsored by Trinity Hypertension & Metabolic Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03635125 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03635125's enrollment target sits among peer trials
40 1397th of 2000 higher than 534 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI